# FDA recall D-1538-2014

> **Teva Pharmaceuticals USA** · Class II · drug recall initiated 2014-06-05.

## Product

Carbidopa and Levodopa Tablets USP, 25mg/100mg, 1000 count bottle, Rx only,  Manufactured in Israel by Teva Pharmaceutical IND, LTD., Jeruselem, Israel, for Teva Pharmaceuticals USA, Sellersville, PA,  NDC 0093-0293-10

## Reason for recall

Failed Tablet/Capsule Specifications: Teva is recalling one lot of Carbidopa and Levodopa Tablets USP, 25mg/100mg due to the potential for superpotent tablets.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1538-2014
- **Recalling firm:** Teva Pharmaceuticals USA
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-06-05
- **Report date:** 2014-08-20
- **Termination date:** 2014-12-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** North Wales, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1538-2014

## Citation

> AI Analytics. FDA recall D-1538-2014. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-1538-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*